SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 9 filers reported holding SEAGEN INC in Q4 2023. The put-call ratio across all filers is 0.99 and the average weighting 1.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $391,200 | +13.1% | 1,844 | +2.6% | 0.01% | +16.7% |
| Q2 2023 | $346,040 | -56.7% | 1,798 | -54.5% | 0.01% | -60.0% |
| Q1 2023 | $799,348 | +344.6% | 3,948 | +182.2% | 0.02% | +400.0% |
| Q4 2022 | $179,783 | -5.9% | 1,399 | 0.0% | 0.00% | -25.0% |
| Q3 2022 | $191,000 | -23.0% | 1,399 | 0.0% | 0.00% | -20.0% |
| Q2 2022 | $248,000 | +22.8% | 1,399 | 0.0% | 0.01% | +66.7% |
| Q1 2022 | $202,000 | -9.8% | 1,399 | -3.7% | 0.00% | -25.0% |
| Q4 2021 | $224,000 | +71.0% | 1,452 | +88.8% | 0.00% | +100.0% |
| Q3 2021 | $131,000 | +8.3% | 769 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $121,000 | -5.5% | 769 | -16.3% | 0.00% | 0.0% |
| Q1 2021 | $128,000 | -5.2% | 919 | +19.5% | 0.00% | -33.3% |
| Q4 2020 | $135,000 | – | 769 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 47,288,259 | $7,465,870,000 | 32.79% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 145,000 | $22,868,000 | 6.04% |
| Lagoda Investment Management, L.P. | 59,780 | $9,438,000 | 4.40% |
| Avidity Partners Management LP | 640,000 | $101,043,000 | 2.73% |
| PFM Health Sciences, LP | 482,985 | $76,254,000 | 2.39% |
| Boxer Capital, LLC | 400,000 | $63,152,000 | 2.23% |
| Redmile Group, LLC | 771,385 | $121,786,000 | 1.80% |
| Woodline Partners LP | 577,655 | $91,200,000 | 1.70% |
| Rhenman & Partners Asset Management AB | 157,925 | $24,933,000 | 1.69% |
| Parkman Healthcare Partners LLC | 45,176 | $7,132,000 | 1.56% |